For the Inventor, By the Inventor

Enter assignee name

Cambridge, United Kingdom

Prometic Pharma Smt Limited

USPTO Granted Patents = 12

% Expired Patents = 58.3

EPO Patents = 8

Forward Citations = 18

Loading Chart...

Loading Chart...

14 inventors (with patents filed for the assignee):

Lyne Gagnon (11 out of 28 patents)

Brigitte Grouix (8 out of 19 patents)

Pierre Laurin (7 out of 16 patents)

4. Boulos Zacharie (6 out of 29 patents)

5. Christopher L Penney (4 out of 21 patents)

6. François Sarra-Bournet (3 out of 3 patents)

7. Lilianne Geerts (3 out of 7 patents)

8. Martin Leduc (3 out of 3 patents)

9. Valérie Perron (3 out of 9 patents)

10. Shaun Abbott (3 out of 10 patents)

11. Jean-Francois Bienvenu (2 out of 3 patents)

12. Jean-François Bienvenu (1 out of 4 patents)

13. Vincent Pichette (1 out of 1 patent)

14. Francois Leblond (1 out of 1 patent)

15. Mouna Lagraoui (1 out of 1 patent)

12 patents: Sort by Forward Citations

1. 11267779 - Substituted aromatic compounds for the treatment of pulmonary fibrosis, liver fibrosis, skin fibrosis and cardiac fibrosis (2022-03-08),

2. 10815183 - Substituted aromatic compounds and pharmaceutical uses thereof (2020-10-27),

3. 10550066 - Substituted aromatic compounds and related method for the treatment of fibrosis (2020-02-04),

4. 10450258 - Substituted aromatic compounds for the treatment of pulmonary fibrosis, liver fibrosis, skin fibrosis and cardiac fibrosis (2019-10-22),

5. 10391073 - Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration (2019-08-27),

6. 10105331 - Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of diabetes (2018-10-23),

7. 10023518 - Substituted aromatic compounds and related method for the treatment of fibrosis (2018-07-17),

8. 9938221 - Substituted aromatic compounds and pharmaceutical uses thereof (2018-04-10),

9. 9884802 - Substituted aromatic compounds for the treatment pulmonary fibrosis, liver fibrosis, skin fibrosis and cardiac fibrosis (2018-02-06),

10. 9682054 - Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis (2017-06-20),

11. 9532962 - Medium-chain length fatty acids and glycerides as nephroprotection agents (2017-01-03),

12. 9447016 - Method for the preparation of triglycerides of medium-chain length fatty acids (2016-09-20),

Company Overview

Prometic Pharma Smt Limited, based in Cambridge, GB, specializes in the development of innovative biopharmaceutical products. The company focuses on advanced therapies for rare diseases, leveraging its expertise in protein engineering and bioprocessing. Prometic is dedicated to addressing unmet medical needs through its research in biologics and small molecules, aiming to improve patient outcomes and enhance the quality of life for individuals affected by complex health conditions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

12 Patents

#85 in Cambridge

#1,458 in United Kingdom

#48,163 in the World

Cambridge, United Kingdom

Prometic Pharma Smt Limited

Forward Citations = 18

14 inventors:

Lyne Gagnon (11 out of 28 patents)

Brigitte Grouix (8 out of 19 patents)

Pierre Laurin (7 out of 16 patents)

4. Boulos Zacharie (6 out of 29 patents)

5. Christopher L Penney (4 out of 21 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Prometic Pharma Smt Limited. Retrieved from https://idiyas.com/company/prometic-pharma-smt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…